PDF Cover

Orbital Atherectomy Systems Market

Orbital Atherectomy Systems Market

The market for Orbital Atherectomy Systems was estimated at $608 million in 2024; it is anticipated to increase to $928 million by 2030, with projections indicating growth to around $1.32 billion by 2035.

Report ID:DS1801289
Author:Debadatta Patel - Senior Consultant
Published Date:June 2025
Datatree
Orbital Atherectomy Systems
Share
Connect
Report Price: $4,200
Report Summary
Table of Contents
Methodology
Market Data

Global Orbital Atherectomy Systems Market Outlook

Revenue, 2024

$608M

Forecast, 2034

$1.23B

CAGR, 2025 - 2034

7.3%

The Orbital Atherectomy Systems industry revenue is expected to be around $652.6 million in 2025 and expected to showcase growth with 7.3% CAGR between 2025 and 2034. The growth of the Orbital Atherectomy Systems market is thriving due to factors both within and outside the industry's scope. The increasing number of individuals and the prevalence of peripheral artery diseases are notable internal factors contributing to this trend. The market is also driven by advancements in atherectomy procedures minimally invasive techniques gaining popularity and a strong focus being placed on healthcare infrastructure improvements. These combined elements have led to growth in the industry making investments, in Orbital Atherectomy Systems promising for those involved in the market.

Orbital Atherectomy Systems are medical tools utilized to eliminate atherosclerotic plaque from patients arteries effectively and safely without harming the surrounding healthy artery walls due to their distinctive cutting mechanism known as differential cutting feature. These systems find uses in treating both cardiovascular and peripheral arterial conditions and are highly regarded as vital instruments in the healthcare field. Moreover the increasing focus on enhancing treatment efficiency and precision while minimizing invasiveness has led to a growing need for Orbital Atherectomy Systems, in practice.

Orbital Atherectomy Systems market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2024-2034
Orbital Atherectomy Systems Market Outlook

Market Key Insights

  • The Orbital Atherectomy Systems market is projected to grow from $608.2 million in 2024 to $1.23 billion in 2034. This represents a CAGR of 7.3%, reflecting rising demand across Vascular Surgery, Peripheral Artery Disease Management and Coronary Artery Disease Treatment.
  • Boston Scientific, Cardiovascular Systems Inc., and Medtronic PLC are among the leading players in this market, shaping its competitive landscape.

  • U.S. and Germany are the top markets within the Orbital Atherectomy Systems market and are expected to observe the growth CAGR of 4.7% to 7.0% between 2024 and 2030.
  • Emerging markets including Brazil, India and South Africa are expected to observe highest growth with CAGR ranging between 8.4% to 10.1%.
  • Transition like Technological Advancements in Medical Devices is expected to add $84 million to the Orbital Atherectomy Systems market growth by 2030

    .
  • The Orbital Atherectomy Systems market is set to add $622 million between 2024 and 2034, with manufacturer targeting Peripheral Artery Disease & Diabetic Foot Ulcers Applications projected to gain a larger market share.
  • With

    increasing prevalence of peripheral artery disease, and

    groundbreaking technological advancements, Orbital Atherectomy Systems market to expand 102% between 2024 and 2034.

orbital atherectomy systems market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032
Orbital Atherectomy Systems - Country Share Analysis

Opportunities in the Orbital Atherectomy Systems

Manufacturers of Orbital Atherectomy Systems stand to gain from forming partnerships and collaborations as these can also aid in sharing knowledge and enhancing product development and innovation efforts effectively. Additionally such partnerships can assist in expanding market presence and enabling businesses to respond to changing consumer demands.

Growth Opportunities in North America and Asia Pacific

In North America's Orbital Atherectomy Systems market has experienced growth due to advances in technology and the rising prevalence of peripheral artery disease. The United States stands out as a center for innovation and production with top companies like Cardiovascular Systems Inc and Boston Scientific Corporation headquartered there. The high uptake of invasive treatments and robust healthcare facilities have further boosted market interest. Competition, among leading players and strict regulatory measures could hinder market growth.
In the Asia Pacific region there is a growing need for Orbital Atherectomy Systems because of the increasing number of people with heart problems and the growing population of adults in the region. China and India are seen as promising markets for companies due to their developing healthcare industries. Furthermore the construction of healthcare facilities and higher government spending, in healthcare are also contributing to the markets expansion. Insufficient knowledge regarding these cutting edge systems might impede market advancement in this region.

Market Dynamics and Supply Chain

01

Driver: Increasing Prevalence of Peripheral Artery Disease, and Rise in Healthcare Expenditures

The increasing occurrence of artery disease is also significantly driving the need for Orbital Atherectomy Systems in medical procedures to address blocked arteries in individuals with PAD due to the aging population and the growing cases of PAD requiring advanced treatment options like these systems to be more, in demand.

The escalating healthcare spending globally is also fueling the market for Orbital Atherectomy Systems as well. Developed and developing countries alike are also progressively investing in their healthcare sectors to provide improved medical and surgical solutions. These systems, with their potential to offer effective results in artery clearance procedures, are also significantly benefitting from these investment trends.

The rise of technology in the healthcare sector continues to propel the market for Orbital Atherectomy Systems forward. With the integration of features like minimally invasive procedures and real time imaging coupled with high cutting precision is also influencing the adoption rate. Research and development efforts focused on enhancing these systems in terms of safety and effectiveness are also paving the way, for market expansion.

02

Restraint: High Cost of Procedures

Orbital Atherectomy Systems play a role in treating peripheral artery diseases by providing unique advantages to patients undergoing such procedures. However the significant drawback lies in the nature of these treatments which acts as a major barrier. Many healthcare professionals and individuals are hesitant to proceed due to the commitment required post surgery that encompasses costly disposables and device expenses resulting in a notable decrease, in demand.

03

Opportunity: Tapping into Emerging Markets and Technological Advancements and Innovations

In growing economies like India and China where healthcare spendings on the rise steadily there is a notable opportunity for Orbital Atherectomy Systems to thrive. The increasing desire for cutting edge healthcare services in these areas creates an unexplored market sector. The growing preference for invasive medical procedures and better healthcare accessibility could fuel the demand for Orbital Atherectomy Systems, within these regions.

In the field of medicine progress is ongoing as findings and advancements open doors to enhanced treatment choices. Through enhancements in Orbital Atherectomy Systems like increased effectiveness there is potential for patient results and greater acceptance among healthcare professionals. This development points to a growing market opportunity, for advanced and efficient Orbital Atherectomy Systems.

04

Challenge: Stringent Regulatory Guidelines

Orbital Atherectomy Systems, being a branch of invasive devices, are scrupulously monitored by regulatory authorities such as the FDA and CE. The rigorous process of gaining approvals, compliance to stern safety standards, and clinical trials present significant barriers. This often slows down the launch of advanced Atherectomy Systems, affecting market dynamics by limiting novel product availability.

Supply Chain Landscape

1

Raw Materials Procurement

3MDuPont
2

Component Device Manufacturing

Cardiovascular Systems Inc.Philips Healthcare
3

Distribution & Sales

MedtronicCardinal Health
4

End-Users

HospitalsAmbulatory Surgical CentersCardiology Clinics
Orbital Atherectomy Systems - Supply Chain

Applications of Orbital Atherectomy Systems in Vascular Surgery, Peripheral Artery Disease Management & Coronary Artery Disease Treatment

Vascular Surgery : Orbital atherectomy systems remain a staple choice for vascular surgeries where high precision and efficiency are requisite. The pivotal role of atherectomy systems in using an orbital mechanism allows advanced treatment for peripheral artery disease , particularly in chronic total occlusions with severe calcification. Key players leading the market, such as Cardiovascular Systems Inc, have pioneered unique orbital atherectomy systems for vascular surgeries, specifically dedicated to improving patient health outcomes.
Coronary Artery Disease Treatment : In treating coronary artery disease, high efficacy and safety standards are maintained with the use of orbital atherectomy systems. These high-speed devices ablate plaque in the coronary artery, creating a safe pathway for further angioplasty or stenting. Industry growth in this field is led by manufacturers who emphasize generating a technological edge like Boston Scientific, known for their innovative atherectomy systems, one of which is the Rotablator Rotational Atherectomy System.
Peripheral Artery Disease Management : Orbital atherectomy systems play a significant role in peripheral artery disease management, providing an intelligent solution to reducing plaque in lower extremity arteries. Devices such as Diamondback 360 Peripheral Orbital Atherectomy System by Cardiovascular Systems Inc, have become crucial in embarking upon an optimized approach to PAD treatment. These devices facilitate smoother blood flow, thereby enhancing patient safety and comfort.

Recent Developments

December 2024 : Medtronic Inc., a leading provider in the market, introduced AI-powered Orbital Atherectomy Systems to offer more precise and efficient plaque removal
October 2024 : Boston Scientific Corporation launched a next-gen Orbital Atherectomy System featuring improved stent integration technology, setting a new standard in the industry
August 2024 : Philips Healthcare incorporated advanced imaging capability within their Orbital Atherectomy Systems, enabling better visualization and control during interventional procedures.

Orbital Atherectomy Systems have emerged as a transformative technological solution within the medical device industry. These advanced systems offer innovative ways to streamline peripheral arterial disease and coronary artery disease treatment, resulting in a surge of interest and uptake among global care providers.

Impact of Industry Transitions on the Orbital Atherectomy Systems Market

As a core segment of the Medical Device industry, the Orbital Atherectomy Systems market develops in line with broader industry shifts. Over recent years, transitions such as Technological Advancements in Medical Devices and Increasing Demand for Minimally Invasive Procedures have redefined priorities across the Medical Device sector, influencing how the Orbital Atherectomy Systems market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Technological Advancements in Medical Devices

Over the ten years or so there have been some big leaps forward in the realm of medical devices. Especially in cardiovascular intervention tools like Orbital Atherectomy Systems. One cool thing about them is how they've made invasive procedures on peripheral and coronary arteries possible thanks to nifty features like dual action diamond tips and different sand levels. Now doctors can tweak plaque better and position stents more effectively, for better patient outcomes. All these improvements have really stepped up patient safety and the success rates of these procedures worldwide. This industry transition is expected to add $84 million in the industry revenue between 2024 and 2030.
02

Increasing Demand for Minimally Invasive Procedures

Over the past few years, there has been a growing prevalence of cardiovascular diseases, consequently increasing the need for minimally invasive heart treatment procedures. Orbital Atherectomy Systems play a vital role in these procedures, providing efficient plaque modification during angioplasties. The paradigm shift towards minimally invasive atherectomy procedures has spurred increased investment in research and development activities, propelling advancements and expanding applications for Orbital Atherectomy Systems.

Related Reports

Loading related reports...